A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases
Frontiers in Cellular and Infection Microbiology · 12.08.2026 · 16
DOI: 10.3389/fcimb.2026.1916422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.08.2026. Verfasst von Huipeng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, DNA, Viral, Diarrhea. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
To characterize the clinical spectrum and outcomes of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases (EBV-FDH).
Methods
This retrospective case series study was conducted at Qilu Hospital of Shandong University. We identified patients aged ≥14 years presenting with the triad of fever (>38 °C), diarrhea (≥3 loose stools/day), and hematochezia, accompanied by plasma EBV DNA positivity (≥500 copies/mL). All cases underwent a standardized diagnostic protocol including comprehensive laboratory tests, imaging, endoscopic and histopathological evaluation. Final diagnoses were established through multidisciplinary consensus.
Results
The cohort (mean age 46.5 years; 71.4% male) frequently had immune abnormalities (50%). Lymphadenopathy (78.6%) and weight loss (50%) were common. Laboratory examinations revealed universal hypocholesterolemia, with reduced ApoB and elevated Lp(a) further characterizing the lipid-metabolic disturbance. Endoscopy revealed widespread ulcers. Diagnoses included CAEBV, ENKTL, IBD, etc. Misdiagnosis occurred in 57.1% of cases. Treatments varied (corticosteroids, chemotherapy, surgery). Treatment strategies were heterogeneous. Despite high overall mortality (64.3%), five patients achieved long-term survival, including one who received intensive therapies such as hematopoietic stem cell transplantation and combination chemotherapy, suggesting a potential benefit of aggressive intervention in selected cases.
Conclusions
EBV-FDH is a severe syndrome with high mortality, often misdiagnosed initially. A high clinical suspicion and multimodal evaluation are crucial. Aggressive treatment, including surgery and HSCT, can enable survival in select patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Zitieren
APA
Zhang, H., Song, X., Liu, Y., Chang, H., Xu, X., Yu, Y., & Zhang, Y. (2026). A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1916422
Vancouver
Zhang H, Song X, Liu Y, Chang H, Xu X, Yu Y, et al. A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1916422
BibTeX
@article{Zhang2026,
author = {Zhang, Huipeng and Song, Xiaojun and Liu, Ying and Chang, Huijun and Xu, Xia and Yu, Yanbo and Zhang, Yan},
title = {A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1916422}
}
EUVIMED